Myriad Genetics (MYGN) EBT Margin (2009 - 2026)
Myriad Genetics (MYGN) posted quarterly EBT Margin of 17.02% for Q1 2026, down 201.0% year-over-year from 16.85% in Q1 2025, and down 301.12% quarter-over-quarter from 4.24% in Q4 2025.
Myriad Genetics (MYGN) EBT Margin (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has reported EBT Margin for 18 consecutive years, with 17.02% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT Margin fell 201.0% year-over-year to 17.02%; the TTM figure through Mar 2026 stood at 48.23% (down 3296.0% YoY), while the FY2025 annual figure was 47.92%, down 3318.0% from the prior year.
- EBT Margin fell to 17.02% in Q1 2026 per MYGN's latest filing, from 4.24% in the prior quarter.
- Across five years, EBT Margin topped out at 4.24% in Q4 2025 and bottomed at 155.14% in Q2 2025.
- Historically, EBT Margin has averaged 28.66% across 5 years, with a median of 17.02% in 2026.
- Annual changes were most pronounced in 2024 — EBT Margin surged 4568 bps — and 2025, when it sank 13755 bps.
- Myriad Genetics' EBT Margin stood at 29.3% in 2022, then jumped by 44 bps to 16.43% in 2023, then retreated by 13 bps to 18.57% in 2024, then soared by 77 bps to 4.24% in 2025, then slumped by 301 bps to 17.02% in 2026.
- Business Quant data shows MYGN's EBT Margin at 17.02% in Q1 2026, 4.24% in Q4 2025, and 12.74% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.21% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.29% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 6.89% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -12.17% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 28.17% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 13.54% |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | -17.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.02% |
| Dec 31, 2025 | -4.24% |
| Sep 30, 2025 | -12.74% |
| Jun 30, 2025 | -155.14% |
| Mar 31, 2025 | -15.01% |
| Dec 31, 2024 | -18.57% |
| Sep 30, 2024 | -9.94% |
| Jun 30, 2024 | -17.59% |
| Mar 31, 2024 | -12.81% |
| Dec 31, 2023 | -16.43% |
| Sep 30, 2023 | -31.89% |
| Jun 30, 2023 | -63.27% |
| Mar 31, 2023 | -29.03% |
| Dec 31, 2022 | -29.30% |
| Sep 30, 2022 | -28.26% |
| Jun 30, 2022 | -9.98% |
| Mar 31, 2022 | -16.01% |
| Dec 31, 2021 | -27.05% |
| Sep 30, 2021 | 23.79% |
| Jun 30, 2021 | -2.01% |